Skip to main content

iwCLL 2023 Main banner

iwCLL X / Twitter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Koji Izutsu, MD, PhD

Director
Department of Hematology, National Cancer Center Hospital, Japan

N/A

Poster(s):

1126 - Significance of sIL-2R and LD in predicting time to first treatment in Japanese CLL patients with early asymptomatic disease.